|
Red Cells
Citations 441-450 of 1173 total displayed.
|
Past content
(since Jan 1997):
|
A mouse model for visualization and conditional mutations in the erythroid lineage
- Achim C. Heinrich, Roberta Pelanda, and Ursula Klingmüller
Blood 2004; 104: 659-666.
[Abstract]
[Full text]
[PDF]
Jun N-terminal kinase promotes proliferation of immature erythroid cells and erythropoietin-dependent cell lines
- Sarah M. Jacobs-Helber and Stephen T. Sawyer
Blood 2004; 104: 696-703.
[Abstract]
[Full text]
[PDF]
Endothelial cell expression of tissue factor in sickle mice is augmented by hypoxia/reoxygenation and inhibited by lovastatin
- Anna Solovey, Rahn Kollander, Arun Shet, Liming C. Milbauer, Stephana Choong, Angela Panoskaltsis-Mortari, Bruce R. Blazar, Robert J. Kelm, Jr, and Robert P. Hebbel
Blood 2004; 104: 840-846.
[Abstract]
[Full text]
[PDF]
Health, economic, and quality-of-life effects of erythropoietin and granulocyte colony-stimulating factor for the treatment of myelodysplastic syndromes: a randomized, controlled trial
- Nicole Casadevall, Pierre Durieux, Stéphanie Dubois, François Hemery, Eric Lepage, Marie-Catherine Quarré, Gandhi Damaj, Stéphane Giraudier, Agnès Guerci, Guy Laurent, Hervé Dombret, Christine Chomienne, Vincent Ribrag, Aspasia Stamatoullas, Jean-Pierre Marie, Anne Vekhoff, Frédéric Maloisel, Robert Navarro, François Dreyfus, and Pierre Fenaux
Blood 2004; 104: 321-327.
[Abstract]
[Full text]
[PDF]
Declining stroke rates in Californian children with sickle cell disease
- Heather J. Fullerton, Robert J. Adams, Shoujun Zhao, and S. Claiborne Johnston
Blood 2004; 104: 336-339.
[Abstract]
[Full text]
[PDF]
Individualized risks of first adverse events in patients with Fanconi anemia
- Philip S. Rosenberg, Yi Huang, and Blanche P. Alter
Blood 2004; 104: 350-355.
[Abstract]
[Full text]
[PDF]
Yolk sac–derived primitive erythroblasts enucleate during mammalian embryogenesis
- Paul D. Kingsley, Jeffrey Malik, Katherine A. Fantauzzo, and James Palis
Blood 2004; 104: 19-25.
[Abstract]
[Full text]
[PDF]
Complications of  -thalassemia major in North America
- Melody J. Cunningham, Eric A. Macklin, Ellis J. Neufeld, Alan R. Cohen, and the Thalassemia Clinical Research Network
Blood 2004; 104: 34-39.
[Abstract]
[Full text]
[PDF]
Superoxide dismutase-3 promotes full expression of the EPO response to hypoxia
- Hagir B. Suliman, Mervat Ali, and Claude A. Piantadosi
Blood 2004; 104: 43-50.
[Abstract]
[Full text]
[PDF]
Value of sequential monitoring of left ventricular ejection fraction in the management of thalassemia major
- Bernard A. Davis, Caoimhe O'Sullivan, Peter H. Jarritt, and John B. Porter
Blood 2004; 104: 263-269.
[Abstract]
[Full text]
[PDF]
|
|
